CCRM in CF
Research type
Research Study
Full title
CCRM in CF : Continuous Contactless Respiratory Monitoring in Cystic Fibrosis
IRAS ID
294760
Contact name
Charles Haworth
Contact email
Sponsor organisation
Royal Papworth Hospital NHS Foundation Trust
ISRCTN Number
ISRCTN 91138792
Clinicaltrials.gov Identifier
Duration of Study in the UK
2 years, 0 months, 1 days
Research summary
The aim of this study is to explore if the Circadia C100 Contactless Respiratory Monitoring System can detect changes in respiratory rate during an inpatient treatment for pulmonary exacerbation in 8 adult patients with cystic fibrosis.
If the system successfully detects changes in respiratory rate, we will then request ethical approval to do a larger study to evaluate if overnight contactless respiratory monitoring in the domestic setting improves an AI derived predictive algorithm for pulmonary exacerbation in adults with cystic fibrosis using the Project Breathe remote monitoring system (which involves the home measurement of lung function, oxygen saturation, activity levels, resting heart rate, weight and general wellbeing).
The Circadia Contactless Respiratory Monitor, is a non-contact device that uses radar technology to monitor respiration, motion, and sleep. The basis for the technology is that ventilation causes mechanical displacement of the chest and abdomen. A radar sensor can thus be used to monitor a person’s respiratory rate and respiration patterns by tracking such motion. Because respiratory rate is measured continuously, respiratory rate variation can also be determined, as can the rate of change over time.
REC name
West of Scotland REC 1
REC reference
21/WS/0025
Date of REC Opinion
23 Mar 2021
REC opinion
Further Information Favourable Opinion